| Literature DB >> 36116000 |
Elindayane Vieira de Souza1, Lara Joana Santos Caxico Vieira2, Sylmara Nayara Pereira Dos Santos2, Sabrina Cerqueira-Santos1, Kérilin Stancine Santos Rocha3, Divaldo Pereira de Lyra4.
Abstract
BACKGROUND: Antimicrobial resistance remains a major global public health concern, and antimicrobial dispensing in community pharmacies is an important factor in preventing this damage. However, the current literature focuses on the technical and attitudinal aspects related to antimicrobial dispensing, with little emphasis on the interventions provided in this service. Thus, this study aimed to determine the antimicrobial dispensing process in community pharmacies.Entities:
Keywords: Antimicrobials; Community pharmacy; Dispensing; Pharmacists
Mesh:
Substances:
Year: 2022 PMID: 36116000 PMCID: PMC9482305 DOI: 10.1186/s13756-022-01157-0
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 6.454
Fig. 1Flow diagram of literature search and screening process
Characteristics of the selected studies
| Study | Country | Aims/objective | Design |
|---|---|---|---|
| Abdelaziz et al. [ | Egypt | To examine antibiotic dispensing patterns in Egyptian community pharmacies | Cross-sectional |
| Abubakar and Tangiisuran [ | Nigeria | To evaluate knowledge, perception, and practices of pharmacists towards dispensing antibiotics without prescription | Cross-sectional |
| Abuirmeileh et al. [ | Jordan | To investigate the common practice of dispensing ABs without prescription in community pharmacies | Qualitative |
| Abujheisha and Ahmed [ | Saudi Arabia | To estimate the pharmacists who tend to dispense antibiotics without a prescription; and the factors associate | Cross-sectional |
| Alabid et al. [ | Malaysia | To explore, assessed and compared dispensing of antibiotics between Pharmacist and General Practitioners | Cross-sectional |
| Almaaytah et al. [ | Jordan | To assess of pharmacies that dispense antibiotics without a prescription and identify the seriousness of such practices | Cross-sectional |
| Al-Tannir et al. [ | Saudi Arabia | To assess of non-prescribed antibiotic sales by pharmacies and compare it with the findings from our 2011 study | Cross-sectional |
| Amirthalingam et al. [ | Malaysia | To assess Pharmacists’ Perceptions and Experiences of Antibacterial Drug Dispensing in Community Pharmacy | Cross-sectional |
| Bahnassi [ | Saudi Arabia | To investigate pharmacists’ practices through conducting, including direct questions and hypothetical scenarios | Qualitative |
| Bahnassi [ | Syria | To investigate the Syrian pharmacists’ attitudes and practices regarding antibiotic dispensing without prescription | Qualitative |
| Beaucage et al. [ | Canada | The impact of a pharmacist telephone follow-up on clinical, costs for patients undergoing antibiotic treatment | Cross-sectional |
| Bin Abdulhak et al. [ | Saudi Arabia | To determine the pharmacies who sell antibiotics without prescriptions, examining the potential risks of such practice | Cross-sectional |
| Chang et al. [ | China | To quantify sales of antibiotics without a prescription and to assess the quality of services in community pharmacies | Cross-sectional |
| Chang et al. [ | China | To quantify non-prescription dispensing of antibiotics at community pharmacies | Cross-sectional and longitudinal |
| Chowdhury et al. [ | Bangladesh | To evaluate the impact of an educational intervention to promote guidelines for better acute respiratory illness | Cross-sectional |
| Contopoulos-Ioannidis et al. [ | Greece | To evaluate the extent of and factors that determine the inappropriate use of antibiotics without a prescription | Cross-sectional |
| Erku and Aberra [ | Ethiopia | To document motivations behind non-prescribed sale of antibiotics among community medicine retail outlets | Cross-sectional |
| Guinovart et al. [ | Spain | To evaluate the information provided by the staff of the pharmacy to a simulated patient requesting an antibiotic | Cross-sectional |
| Hadi et al. [ | Saudi Arabia | To evaluate knowledge, attitude, and practices of pharmacists towards dispensing antibiotics without prescription | Cross-sectional |
| Halboup et al. [ | Yemen | To assess the practice of community pharmacists regarding dispensing antibiotics without a prescription | Cross-sectional |
| Hallit et al. [ | Lebanon | To assess practices of pharmacists towards prescribing or dispensing antibiotics without prescription to children | Cross-sectional |
| Horumpende et al. [ | Tanzania | To Assess antibiotic dispensing practices by community pharmacy and recommend interventions to improve practice | Cross-sectional |
| Hoxha et al. [ | Albanian | To evaluate pharmacists’ tendency to dispense antibiotics without prescription | Cross-sectional |
| Kalungia et al. [ | Zambia | Ascertain the extent of non-prescription sales and dispensing of antibiotics in community pharmacies | Cross-sectional |
| Koji et al. [ | Ethiopia | To determine the rate of over-the-counter dispensary of antibiotics for common childhood illnesses | Cross-sectional |
| Llor and Cots [ | Spain | To quantify the percentage of pharmacies selling antibiotics without an official medical prescription | Cross-sectional |
| Mansour and Al-Kayalib [ | Syria | To explore pharmacists’ knowledge, attitudes, and dispensing habits with respect to antibiotics and microbial resistance, in view of the potential link between these and the practice of dispensing of antibiotics without a medical prescription | Cross-sectional |
| Nyazema et al. [ | Zimbabwean | To assess the quality of private pharmacy practice with a focus on the extent of antibiotic sales without prescription | Cross-sectional |
| Puspitasari et al. [ | Indonesian | To quantify antibiotics sales without a prescription and to explore provision of patient assessment and medicine information related to antibiotics requested with or without a prescription | Cross-sectional |
| Rauber et al. [ | Brazil | To evaluate the antibiotics dispensation | Cross-sectional |
| Shet et al. [ | India | To determine prevalence of non-prescription sale of antimicrobial drugs by pharmacies | Cross-sectional |
| Shi et al. [ | China | To assess non-prescription antibiotic dispensing and assess pharmacy service practice at community pharmacies | Cross-sectional |
| Yaacoub et al. [ | Lebanon | To evaluate the antibiotic prescribing rate for acute bacterial rhinosinusitis in community pharmacies and to study the corresponding attitude and behavior of participants | Cross-sectional |
| Zawahir et al. [ | Sri Lankan | To evaluate the response of community pharmacy staff to an antibiotic product request without a prescription and to explore possible factors influencing such practice | Cross-sectional |
| Zawahir et al. [ | Sri Lankan | To assess responses of community pharmacy staff to pseudo-patients presenting with symptoms of common infections and factors associated with such behaviour | Cross-sectional |
Antimicrobials dispensing practices of studies
| Author, year [References] | Presc | Methods | Scenarios (n) | Sample | Dispenser | Counseling/interventions | Limitations |
|---|---|---|---|---|---|---|---|
| Abdelaziz et al. [ | − | Simulated patient and interview | Case 1: Acute Bronchitis (125) Case 2: Common Cold (113) | 150 community pharmacies | Pharmacists and attendants | Patient’s identification—case 1: 36.8% (n = 46); case 2: 37.2% (n = 42); Doctor visit or prescription—case 1: 3.2% (n = 1); case 2: 3.4% (n = 4); Patient’s condition—case 1: 0,8% (1); Symptoms—case 1: 35.2% (n = 44); case 2: 36.3% (n = 41); Drug allergy—case 1: 1.6% (n = 2); case 2: 0.9% (n = 1) Doctor visit or prescription—33.9% (n = 20); Patient’s condition—86.4% (n = 51); Symptoms 66.1% (n = 39) Prescription of OTC—case 1: 2.4% (7); case 2: 3.6 (4); | N/R |
| Abubakar and Tangiisuran [ | − | Questionnaire | N/A | 98 community pharmacist | Pharmacists | Drug allergy—93.9% (n = 92); Side effects—79.6% (n = 78); Contact pharmacist/doctor if necessary—94.9% (n = 93); Medication adherence—94.9% (n = 93) Referral—69.4% (n = 68); Prescription of OTC—28.6% (n = 28); Health education—92.9% (n = 91) | Social desirability bias Didn’t evaluate pharmacists asked their patients about other medications |
| Abuirmeileh et al. [ | − | Questionnaire | N/A | 54 community pharmacies | Pharmacists | Patient’s condition—70% (n = 38); The use of other medicines—92% (n = 50); Drug allergy—94% (n = 51); Precautions—90% (n = 49) | N/R |
| Abujheisha and Ahmed [ | − | Questionnaire | N/A | 155 community pharmacies | Pharmacists | Drug allergy—91.8% (n = 135); Patient’s condition—87.8% (n = 129); The use of other medicines—90.4% (n = 133); Side effects—Always 90.4% (n = 133); Medication adherence—Always 94.5% (n = 139), Antimicrobial not dispensed—96.6% (n = 142) | N/R |
| Alabid et al. [ | − | Simulated patient | Case 1: Common cold; | 100 visits to 50 pharmacies | Pharmacists | Patient’s identification—Case 1: 12% (n = 12); Patient’s symptoms—Case 1: 87% (n = 87); The use of other medicines—Case 1: 10% (n = 10); Drug allergy—Case 1: 37% (n = 37) | Small sample size Diagnosis and prescription can differ |
| Almaaytah et al. [ | − | Simulated patient | Case 1: Sore throat (41); Case 2: Acute sinusitis (39); Case 3: Otitis media (38); Case 4: Diarrhea (42); Case 5: Urinary tract infection (42) | 202 community pharmacies | Pharmacists | Drug Allergy—Case 1: 45% (n = 18); Case 2: 26.7% (n = 4); Case 5: 2.9% (n = 1); The use of other medicines—Case 1: 2.5% (n = 1); Case 3: 15.4% (n = 4); Case 4: 2.9% (n = 1); Case 5: 2.9% (n = 1) How to take the medicine—Case 1: 87.5% (n = 35); Case 2: 93.3% (n = 14); Case 3: 100% (n = 26); Case 4: 100% (n = 34); Case 5: 97.1% (n = 34); How long the medicine should be taken—Case 1: 17.5% (n = 7); Case 2: 6.7% (n = 1); Case 3: 11.5% (n = 3); Case 4: 20.6% (n = 7); Case 5: 20% (n = 7); Referral—Case 3: 15.4% (n = 4); Case 4: 2.9% (n = 1); Case 5: 2.9% (n = 1) | N/R |
| Al-Tannir et al. [ | − | Simulated patient | Case 1: Sore throat (58); Case 2: Acute sinusitis (56); Case 3: Otitis media (54); Case 4: Acute bronchitis (51); Case 5: Diarrhea (57); Case 6: Urinary tract Infection (51) | 327 community pharmacies | Pharmacists | Patient’s symptoms—Case 1: 43.1% (n = 25); Case 2: 66.1% (n = 35); Case 3: 33.3% (n = 18); Case 4: 52.9% (n = 27); Case 5: 54.4% (n = 31); Case 6: 39.2% (n = 20); Drug allergy—Case 3: 1.9% (n = 1); Case 4: 2% (n = 1); Case 5: 1,8% (n = 1); Case 6: 2% (n = 1) Precautions—Case 6: 9.8% (n = 5); Side effects—Case 4: 33,3% (n = 17); Case 5: 1,8% (n = 1); Case 6: 5,9% (n = 3) Referral—Case 1: 72.4% (n = 42); Case 2: 42.9% (n = 74); Case 3: 88.9% (n = 48); Case 4: 68.6% (n = 35); Case 5: 13.3% (n = 7); Case 6: 80.4% (n = 41) | N/R |
| Amirthalingam et al. [ | − | Questionnaire | N/A | 101 community pharmacist | Pharmacists | Patient’s symptoms—86.4% (n = 89); The use of other medicines—71.8% (n = 74); Patient’s condition—64.1% (n = 66); Drug indication—95.1% (n = 98); How to take the medicine—94.2% (n = 97); Medication adherence—68.9% (n = 71); Contact pharmacist/doctor if necessary—82.5% (n = 85); Precautions—91.3% (n = 94) | The sample size small; Comparisons were not carried |
| Bahnassi [ | − | Semi structured interview | N/A | 150 community pharmacist | Pharmacists | Antimicrobial not dispensed—63% (n = 94); Side effects—33% (n = 49); Modify the antimicrobial—43% (n = 64) | Pharmacists’ self-reporting The interviews were interrupted by customers |
| Bahnassi [ | − | Semi-structured interviews | N/A | 350 community pharmacies | Pharmacists | Patient’s condition—36% (n = 126) Dosing directions—34% (n = 119) Side effects—47% (n = 165) Modify the antimicrobial—37% (n = 130) | -Pharmacists’ discussion could be biased The low number of participants |
| Beaucage et al. [ | + | Telephone follow-up | Case 1: Lower respiratory tract (42); Case 2: Upper respiratory tract (38) | 6 community pharmacies | Pharmacists | Precautions—case 1: 28% (n = 22); case 2: 3% (n = 2); Discontinue antimicrobial—case 1: 2% (n = 2); case 2: 1% (n = 1); Prescription OTC—case 1: 36% (n = 29); case 2: 5% (n = 4); Modify the antimicrobial frequency—case 1: 13% (n = 10); case 2: 1% (1); Contact pharmacist/doctor if necessary—case 1: 9% (n = 7); case 2: 3%(2) Referral—case 1: 9% (n = 7); case 2. 3% (n = 2); Modify the antimicrobial dosage—case 1: 2% (n = 2); case 2: 2% (n = 2); Modify the antimicrobial—case 1: 2% (n = 2); case 2: 1% (n = 1) | N/R |
| Bin Abdulhak et al. [ | − | Simulated patient | Case 1: Sore throat (58); Case 2: Sinusitis (55) Case 3: Otitis (53); Case 4: Bronchitis (44); Case 5: Diarrhea (59);Case6:Urinary infection (58) | 327 community pharmacies | Pharmacists | Patient’s symptoms—Case 1: 40% (n = 23); Case 2: 43% (n = 19); Case 3: 22% (n = 13); Case 4: 62% (n = 36); Case 5: 73% (n = 40); Case 6: 19%(n10) Patient’s condition—Case 1: 9% (n = 5); Case 2: 25% (n = 11); Case 3: 14% (n = 8); Case 4: 14% (n = 8); Case 5: 9% (n = 5); Case 6: 2% (n = 1) Precautions—Case 3: 23% (n = 13) Referral—Case 1: 5% (n = 3); Case 2: 14% (n = 6); Case 3: 10% (n = 6); Case 4: 3% (n = 2); Case 5: 2% (n = 1); Case 6: 47% (n = 25) | N/R |
| Chang et al. [ | − | Simulated patient | Case 1: Pediatric diarrhoea (256); Case 2: Adult acute upper respiratory infection (256) | 256 community pharmacies | Pharmacists and attendants | Patient’s condition—case 1: 40.6% (n = 58); case 2: 80.4% (n = 160); Patient’s symptoms—case 1: 4.2% (n = 6); case 2: 32.2% (n = 64); The use of other medicines—case 1: 2.1% (n = 3); case 2: 6.5% (n = 13); Drug allergy—case 1: 59.4% (n = 85); case 2: 41.2% (n = 82); How to take the medicine—case 1: 17.5% (n = 25); case 2: 9.6% (n = 19); Referral—case 1: 10.6% (n = 12) Antimicrobial not dispensed—case 1: 12.4% (n = 14); case 2: 24.6%(14) | Not differentiate the drugs and services dispensed by a pharmacist |
| Chang et al. [ | − | Simulated patient and practice documentation | Case 1: Paediatric diarrhoea (1554) Case 2: Adult Upper Respiratory Trate Infecction (1896) | 2411 community pharmacies | Pharmacists and attendants | Patient’s condition—Case 1: 64.5% (n = 1554); Case 2: 78.6% (n = 1896); The use of other medicines—Case 1: 9.7% (n = 234); Case 2: 6.6% (159); Patient’s symptoms—Case 1: 18.2% (n = 439); Case 2: 13.4% (n = 323); Drug allergy—Case 1: 16.1% (n = 188); Case 2: 29.2% (n = 494); Antimicrobial not dispensed—Case 1: 21.5% (251); Case 2: 23.8% (403) Referral—Case 1: 6.5% (n = 156); Case 2: 3.8% (n = 92) | They did not sample in proportion to population; No explore the effect of possible interventions |
| Chowdhury et al. [ | − | Simulated patient | N/R | 100 community pharmacies | Pharmacists | Precautions—5% (n = 8); Referral—44% (n = 44); Prescription of OTC—29% (n = 35); | The field staff might not have represented the subtleties of real-life |
| Contopoulos-Ioannidis et al. [ | − | Simulated patient | Case 1: Acute uncomplicated rhinosinusitis with low fever (38.5 °C); Case 2: Acute uncomplicated rhinosinusitis with high fever (40ºC) | 102 community pharmacies 98 community pharmacist | Pharmacists | Patient’s symptoms—Case 1: 30% (n = 15); Case 2: 14% (n = 7); Doctor visit or prescription—Case 1: 20% (n = 10); Case 2: 28% (n = 14); Drug allergy—Case 1. 22% (n = 11); Case 2. 12% (n = 6); Patient’s identification—Case 1: 20% (n = 10); Case 2. 22% (n = 11); Patient’s condition—Case 1: 4% (n = 2); Case 2: 4% (n = 2); The use of other medicines—Case 1: 10% (n = 5); Case 2: 14% (n = 7); Dosage—Case 1: 88% (n = 37); Case 2: 85% (n = 29); How long the medicine should be taken—1: 64% (n = 27); 2: 74% (25) Referral—Case 1. 35% (n = 17); Case 2: 57% (n = 28); Prescription OTC—Case 1: 45% (n = 22); Case 2: 35% (n = 17) | Study design is limited by the fact that the trial was performed in a specific city in Greece |
| Erku and Aberra [ | − | Simulated patient and in-depth interview | Case 1: Acute childhood diarrhea (50); Case 2: Uncomplicated Upper Respiratory Infection (50); | 20 community pharmacies | Pharmacists and attendants | Drug allergy—Case 1: 10.7% (n = 3); Case 2: 14.3% (n = 4); How to take the medicine—Case 1: 38% (n = 19); Case 2: 34% (n = 17); Side effects—Case 1: 46.4% (n = 13); Case 2: 28.6% (n = 8); Non-pharmacological—Case 1: 12% (n = 6); Case 2: 12% (n = 12) Referral—Case 1: 10% (n = 5); Case 2: 8% (n = 4); Antimicrobial not dispensed—Case 1: 14.3% (4); Case 2: 10.7% (n = 3) | The practice behavior in clinical scenarios may not be generalized Recruited smaller mount of pharmacies |
| Guinovart et al. [ | − | Simulated patient | Case 1: Urinary Tract Infection or Sore throat or Acute bronchitis | 220 community pharmacies | Pharmacists and attendants | Drug allergy 26% (n = 31); The use of other medicines 1.7% (n = 2); How long the medicine should be taken 95.8% (n = 114); Referral 36.1% (43) Antimicrobial not dispensed 9.9% (n = 10) | N/R |
| Hadi et al. [ | − | Questionnaire | N/A | 200 community pharmacist | Pharmacists | Drug allergy—Always 76.9% (n = 143), sometimes 15.6% (n = 29); Patient’s condition—Always 70.4% (n = 133), sometimes 16.8% (n = 32); Side effects—Always 64.6% (n = 122), sometimes 24.9% (n = 47); Medication adherence—Always 88.9% (n = 168), sometimes 5.8% (n = 11); How to take the medicine—Always 81% (n = 153), sometimes 12.2% (n = 23); —Antimicrobial not dispensed—Always 61.4% (n = 116), sometimes 20.1% (n = 38); | Self-administered questionnaires such as the one used in this study are prone to social desirability bias |
| Halboup et al. [ | − | Simulated patient | Case 1: Sore throat (199); Case 2: Cough (184); Case 3: Otitis (104); Case 4: Urinary tract infection (96); Case 5: Diarrhea (151) | 1000 community pharmacies | Pharmacists | Patient’s symptoms—Case 2: 83% (n = 166); How to take the medicine—Case 1: 86.4% (n = 172); Case 2: 39.1% (n = 72); Case 3: 95.1% (n = 98); Case 4: 88.5% (n = 85); Case 5: 76% (n = 117); How long the medicine should be take—Case 1: 72.9% (n = 145); Case 2: 6.5% (n = 12); Case 3: 95.1% (n = 97); Case 4: 61.2% (n = 90); Case 5: 50.6% (n = 78); Precautions—Case 1: 15.6% (n = 31); Case 2: 10.8% (n = 20); Case 3: 2% (n = 3); Case 5: 11.9% (n = 65) | Qualitative data was not obtained to further identify the factors that influence or result in the findings of the study |
| Hallit et al. [ | − | Face-to-face interview and Questionnaire | N/A | 202 community pharmacist | Pharmacists | Drug preparation instructions—81.2% (n = 164) How to take the medicine—53% (n = 107) Dosage—46.5% (n = 94) How long the medicine should be taken—47.5% (n = 96) Storage—64.4% (n = 130) Precautions—81.2% (n = 164) Medication adherence—32.2% (n = 65); | A selection bias due to the exclusion of parents acquiring antibiotics from places other than pharmacies |
| Horumpende et al. [ | ± | Simulated patient | Case 1: Cough (16) or Fever (13) or Runny nose (22) or Diarrhoea (15) or Pain urination (16) | 82 community pharmacies (26 part I; 56 part II) | Pharmacists and attendants | Side effects—84.1% (n = 69) Prescription of OTC—25.6% (n = 5); Modify the antimicrobial—6% (n = 5); Antimicrobial not dispensed—no prescription 15.8% (n = 13); | The study was not able to collect data on retailers’ qualifications; |
| Hoxha et al. [ | − | Questionnaire | Case 1: “I need to get a package of amoxicillin” | 450 community pharmacies | Pharmacists | Patient’s identification 97.6% (n = 253); Drug allergy 58.5% (n = 189); Symptoms 53.2% (n = 172) | N/R |
| Kalungia et al. [ | − | Questionnaire | N/A | 73 community pharmacies | Pharmacists and attendants | Drug indication—94.5% (n = 69); Dosage—95.9% (n = 49); Side effects—30.1% (n = 22); Modify the antimicrobial—97.3% (n = 71) | Simulated patients could have been used but for this was difficult within available resources |
| Koji et al. [ | − | Simulated patient | Case 1: Common Cold or Diarrhea or Pneumonia; or Meningitis; | 262 community pharmacies | Pharmacists and attendants | Doctor visit or prescription—62.6% (n = 164); Drug allergy—11.1% (n = 29); Patient’s symptoms—40.8% (n = 107) | N/R |
| Llor and Cots [ | − | Simulated patient | Case 1: Urinary tract infection—(69); Case 2: Sore throat (69); Case 3: Acute bronchitis (59); | 197 community pharmacies | Pharmacists and attendants | Patient’s symptoms—case 1: 69.1% (n = 38); case 2: 70.8% (n = 17); case 3: 60% (n = 6); Drug allergy—case 1: 9.1% (n = 5); case 2: 33.3% (n = 8); case 3: 20% (n = 2); Contraindications—case 1: 3.6% (n = 2); How to take the medicine—case 1: 94.5% (n = 52); case 2: 70.8% (n = 17); case 3: 50% (n = 5) How long the antibiotic should be taken—case 1: 94.5% (n = 52); case 2: 37.5% (n = 9); case 3: 10% (n = 1); Contact pharmacist/doctor if necessary—case 1: 1.8% (n = 1); case 2: 12.5% (n = 3) Antimicrobial not dispensed—case 1: 20.3% (n = 14); case 2: 65.2% (n = 45); case 3: 83.1% (n = 49) | Not distinguish whether the person who attended to the patient was a pharmacist |
| Mansour and Al-Kayali [ | − | Questionnaire | N/A | 250 community pharmacies | Pharmacists | Medication adherence—Always 62.4% (n = 108), sometimes 19.6% (n = 34); Side effects—Always 47.4% (n = 82), sometimes 14.4% (n = 25); Precautions—Always 59% (n = 102), sometimes 18.5% (n = 32); Health education—Always 51.4% (n = 89), sometimes 21.4% (n = 37); | There is the possibility that participants may over-report desirable behaviors |
| Nyazema et al. [ | - | Simulated patient and Interviews | Case 1: Vaginal discharge and itching Case 2: Urethral discharge Case 3: A child with acute diarrhoea | 44 community pharmacies | Pharmacists | The use of other medicines—Case 1: 18% (n = 10); Case 2: 3% (n = 2); Patient’s symptoms—Case 1: 91% (n = 52); Case 2: 33% (n = 21) Non-pharmacological—Case 3: 37% (n = 25) Side effects—Case 3: 2% (n = 1) Precautions—Case 1: 19% (n = 11) Prescription of OTC—Case 1: 58% (n = 33); Case 3: 87% (n = 58); | Repeated visits by simulated clients would have been preferable |
| Puspitasari et al. [ | ± | Simulated patient | Patient requestes: Case 1: Ciprofloxacin 500 mg Case 2: Tetracycline 250 mg Case 3: Amoxicillin dry syrups 125 mg per 5 ml | 105 community pharmacies | Pharmacists and attendants | Patient’s identification—Case 1: 2% (n = 2); Case 2: 2% (n = 2); Case 3: 31% (n = 23); Patient’s symptoms—Case 1: 2% (n = 2); Case 2: 8% (n = 7); Case 3: 5%(4) How to take the medicine—Case 1: 35% (n = 31); Case 2: 68% (n = 60); Case 3: 70% (n = 52); How long the medicine should be taken—Case 1: 21% (n = 18); Case 2: 6% (n = 5); Case 3: 43% (32); Side effects—Case 1: 1% (n = 1); Precautions—Case 1: 1% (n = 1); Medication adherence—Case 1: 2% (n = 2); Case 3: 1% (n = 1); Storage—Case 3: 14% (n = 10) | Data on pharmacy staff’s qualifications were based on self-report of respondents |
| Rauber et al. [ | − | Questionnaire | N/A | 46 community pharmacist | Pharmacists | Drug allergy—15.1% Patient’s condition—15.1% Patient’s identification—1% How long the medicine should be taken—1.8% Drug interactions—12.6%; Side effects—7.2%; Posology—46.7% Antimicrobial not dispensed—1.8% | Relied on data reported by the respondents |
| Shet et al. [ | − | Simulated patient | Case 1: Upper respiratory tract infection in adult (115); Case 2: Acute gastro-enteritis in child (146); | 261 community pharmacies | Pharmacists | Dosage—Case 1: 96.3% (n = 79); Case 2: 23.9% (n = 22); How long the medicine should be taken—Case 1: 91.5% (n = 75); Case 2: 15.2 (n = 14); Non-pharmacological—Case 1: 18.3% (n = 21); Case 2: 12.3% (n = 18); Referral—Case 1: 21.7% (n = 25); Case 2: 33.6% (n = 49); Antimicrobial not dispensed—Case 1: 9.1% (n = 3); Case 2: 24.1% (13); | Did not distinguish whether the dispensing workforce in pharmacies |
| Shi et al. [ | − | Simulated patient | Case 1: Adult acute cough associated with a common cold (n = 100); Case 2: A pediatric acute cough associated with a common cold (n = 81) | 147 community pharmacies | Pharmacists and attendants | Patient’s symptoms—Case 1: 82.2% (n = 60); Case 2: 82.4% (n = 61); The use of other medicines—Case 1: 82.2% (n = 121); Case 2: 82.4% (61); Doctor visit or prescription—Case 1: 19.2% (n = 14); Case 2: 10.8% (8); Drug allergy—Case 1: 42.5% (n = 31); Case 2: 35.1% (n = 26); Non-pharmacological—Case 1: 1.4% (n = 1); 6.8% (n = 5); Side effects—Case 1: 2.7% (n = 2); Case 2: 4% (n = 3); Prescription of OTC—Case 1: 21.9% (n = 16); Case 2: 40.5% (30); Referral—Case 1: 5.5% (n = 4) | Did not distinguish whether the respondent was a licensed pharmacist or pharmacy assistant |
| Yaacoub et al. [ | ± | Simulated patient | Case 1: Bacterial rhinosinusitis | 250 community pharmacies | Pharmacists and attendants | Patient’s identification—19.6% (n = 49); Drug allergy—3.2% (n = 8); Patient’s symptoms—43.2% (n = 108) Precautions—2% (n = 5); Drug indication—10.4% (n = 26); Referral—10.4% (n = 26) | The sociodemographic characteristics of the participants were not available |
| Zawahir et al. [ | − | Simulated patient | Patient requests: Case 1: Erythromycin; Case 2: Amoxicillin Case 3: Metronidazole 500 mg; Case 4: Ciprofloxacin | 242 community pharmacies | Pharmacists and attendants | Patient’s identification—Case 1: 18.3% (n = 11); Case 2: 27.4 (n = 17); Case 3: 17.5% (n = 10); Case 4: 33.3% (21); Patient’s symptoms—Case 1: 1.7% (n = 1); Case 2: 1.6% (n = 1); Case 3: 1.8% (n = 1); The use of other medicines—Case 2: 6.5% (n = 4); Case 3: 1.8% (n = 1); Patient’s condition—Case 1: 6.7% (n = 4); Case 2: 14.5% (n = 9); Case 3: 15.8% (9); Case 4: 11.1% (7); Referral—Case 1: 6.7% (n = 4); Case 2: 11.3% (n = 7); Case 3: 1.8% (n = 1); Case 4: 6.3% (4); | Interpersonal variations between SCs impacted how they behaved in the pharmacies, and hence how pharmacy staff behaved |
| Zawahir et al. [ | − | Simulated patient | Case 1: Sore throat (60); Case 2: Common cold (60); Case 3: Diarrhea (60); Case 4: UTI (62) | 242 community pharmacies | Pharmacists and attendants | Patient’s symptoms—Case 1: 12% (n = 7); Case 2: 18% (n = 11); Case 3: 10% (n = 6); Case 4: 2% (n = 2); The use of other medicines—Case 1: 1.7% (n = 4); Case 2: 3% (n = 2); Case 3: 2% (n = 1); Case 4: 2% (n = 1); Drug allergy—Case 1: 19% (n = 5); Case 3: 7% (n = 2); Case 4: 9% (n = 3); How to take the medicine—Case 1: 62% (n = 16); Case 2: 33% (n = 3); Case 3: 53% (n = 16); Case 4: 71% (n = 24); How long the medicine should be taken—Case 1: 15% (n = 4); Case 3: 23% (n = 7); Case 4: 32% (n = 11); Referral—Case 1: 10% (n = 6); Case 2: 23% (n = 14); Case 3: 15% (n = 9); Case 4: 24% (n = 15) | A self- selection of the study participants may have impacted the study findings |
NR, Not related; N/A, Not applicable; Presc., Prescription; ( −), Without prescription; ( +), With prescription; ( ±) With and without prescription
Practices of antimicrobials dispensing for clinical cases
| Interventions | Diarrhea (n = 2375) | Upper respiratory tract infection (n = 2355) | Sore throat (n = 485) | Acute sinusites (n = 400) | Urinary tract infection (n = 378) | Cough (n = 365) | Acute bronchitis (n = 273) | Common cold (n = 273) | Otitis media (n = 249) | Lower respiratory tract infection (n = 42) |
|---|---|---|---|---|---|---|---|---|---|---|
| Patient’s identification | – | – | – | 49 (12%) | – | – | 82 (29%) | 54 (20%) | – | – |
| Patient’s condition | 1065 (45%) | 1650 (70%) | 5 (1%) | 11 (3%) | 1 (0.2%) | – | 9 (3%) | – | 8 (3.2%) | – |
| Patient’s symptoms | 522 (22%) | 387 (16%) | 72 (14.8%) | 162 (40%) | 70 (18.5%) | 287 (78%) | 77 (27%) | 139 (51%) | 31 (12%) | – |
| Drug allergy | 279 (12%) | 580 (24.6%) | 31 (6.4%) | 26 (6.5%) | 10 (2.6%) | 57 (15.6%) | 5 (1.8%) | 38 (14%) | 1 (0.4%) | – |
| The use of other medicines | 239 (10%) | 172 (7.3%) | 5 (1%) | – | 2 (0.5%) | 182 (50%) | – | 12 (4.4%) | 4 (1.6%) | – |
| Contraindications | – | – | – | – | 2 (0.5%) | – | – | – | – | – |
| Doctor visitor prescription | – | – | – | – | – | 16 (4.4%) | – | 4 (1.4%) | – | – |
| Drug preparation instructions | – | – | – | – | – | – | – | – | – | – |
| Drug indication | – | – | – | 26 (6.5%) | – | – | – | – | – | – |
| Drug interactions | – | – | – | – | – | – | – | – | – | |
| How to take the medicine | 192 (8%) | 36 (1.5%) | 240 (49%) | 14 (3.5%) | 195 (51%) | 72 (19.7%) | 5 (1.8%) | 3 (1%) | 124 (50%) | – |
| Dosage | 22 (0.9%) | 79 (3%) | – | – | – | – | – | – | – | |
| How long the medicine should be taken | 106 (4.5%) | 75 (3.2%) | 165 (34%) | 1 (0.25%) | 160 (42%) | 12 (3.3%) | 1 (0.3%) | – | 100 (40%) | – |
| Medication adherence | – | – | – | – | – | – | – | – | – | – |
| Discontinue antimicrobial | – | 1 (0.04%) | – | – | – | – | – | – | – | 2 (4.8%) |
| Storage | – | – | – | – | – | – | – | – | – | – |
| Health education | – | – | – | – | – | – | – | – | – | – |
| Non-pharmacological measures | 24 (1%) | 33 (1.4%) | – | – | – | 6 (1.6%) | – | – | – | – |
| Precautions | 65 (2.7%) | 2 (0.08%) | 31 (6.4%) | 5 (1.2%) | 5 (1.3%) | 20 (5.5%) | – | – | 16 (6.4%) | 22 (52%) |
| Side effects | 14 (0.6%) | 8 (0.3%) | – | – | 3 (0.8%) | 5 (1.3%) | 17 (6%) | – | – | – |
| Referral | 240 (10%) | 94 (4%) | 45 (9.3%) | 106 (26%) | 81 (21%) | 4 (1.1%) | 37 (13%) | 14 (5%) | 58 (23%) | 7 (16%) |
| Contact pharmacist/doctor if necessary | – | 2 (0.08%) | 3 (0.6%) | – | 1 (0.2%) | – | – | – | 7 (16%) | |
| Modify the antimicrobial | – | 1 (0.04%) | – | – | – | – | – | – | 2 (4.8%) | |
| Modify the antimicrobial dosage | – | 2 (0.08%) | – | – | – | – | – | – | 2 (4.8%) | |
| Modify the antimicrobial frequency | – | 1 (0.04%) | – | – | – | – | – | – | 10 (23.8%) | |
| Prescription of OTC | – | 4 (0.17%) | – | – | – | 46 (12.6%) | 7 (2.5%) | 4 (1.4%) | – | 29 (69%) |
| Antimicrobial not dispensed | 269 (11%) | 423 (18%) | 9.3% | – | 14 (3.7%) | 49 (17%) | – | – | – | |
The total n of each clinical case is equivalent to the sum of the n of the studies included for each scenario